Pharsight

Drugs that contain Pioglitazone Hydrochloride

1. Actos patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6166043 TAKEDA PHARMS USA Pharmaceutical composition
Jun, 2016

(7 years ago)

US6150384 TAKEDA PHARMS USA Pharmaceutical composition
Jun, 2016

(7 years ago)

US6166042 TAKEDA PHARMS USA Pharmaceutical composition
Jun, 2016

(7 years ago)

US6150383 TAKEDA PHARMS USA Pharmaceutical composition
Jun, 2016

(7 years ago)

US5965584 TAKEDA PHARMS USA Pharmaceutical composition
Jun, 2016

(7 years ago)

US6271243 TAKEDA PHARMS USA Pharmaceutical composition
Jun, 2016

(7 years ago)

US6329404 TAKEDA PHARMS USA Pharmaceutical composition
Jun, 2016

(7 years ago)

US6172090 TAKEDA PHARMS USA Pharmaceutical composition
Jun, 2016

(7 years ago)

US6211205 TAKEDA PHARMS USA Pharmaceutical composition
Jun, 2016

(7 years ago)

US6303640 TAKEDA PHARMS USA Pharmaceutical composition
Aug, 2016

(7 years ago)

Market Authorisation Date: 15 July, 1999

Treatment: A method for reducing the amount of active components administered to a diabetic patient by administering an insulin sensitivity enhancer (including pioglitazone) in combination with a biguanide as sa...

Dosage: TABLET;ORAL

How can I launch a generic of ACTOS before it's drug patent expiration?
More Information on Dosage

ACTOS family patents

Family Patents